MedPath
FDA Approval

Atenolol and Chlorthalidone

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
September 22, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Atenolol(50 mg in 1 1)
Chlorthalidone(25 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

PD-Rx Pharmaceuticals, Inc.

156893695

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

PD-Rx Pharmaceuticals, Inc.

PD-Rx Pharmaceuticals, Inc.

PD-Rx Pharmaceuticals, Inc.

156893695

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Atenolol and Chlorthalidone

Product Details

NDC Product Code
55289-993
Application Number
ANDA073665
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 22, 2023
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POVIDONE K29/32Inactive
Code: 390RMW2PEQClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
AtenololActive
Code: 50VV3VW0TIClass: ACTIBQuantity: 50 mg in 1 1
Code: Q0MQD1073QClass: ACTIBQuantity: 25 mg in 1 1
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
© Copyright 2025. All Rights Reserved by MedPath